Serum Exosome-derived Biomarkers for the Early Detection of Oral Squamous Cell Carcinoma
Overview
Affiliations
Blood exosomes help regulate communication between tumour cells, moderating their behaviour. We sought to determine the protein content in serum exosomes (SEs), to characterise SEs, and to discover novel clinical biomarkers of oral squamous cell carcinoma (OSCC). Differentially expressed proteins (DEPs) of OSCC were identified using proteomics and then analysed using bioinformatics, before validation using ELISA, IHC, and RT-PCR. The influence of SEs on oral cancer cells was detected using CCK-8 and migration assays. Twelve DEPs were found in SEs from OSCC. Four proteins were targeted for further verification. New biomarkers exhibiting high sensitivity and specificity in diagnosing OSCC comprised C-reactive protein (CRP), von willebrand factor (VWF), and leucine-rich alpha-2-glycoprotein (LRG). Combined biomarkers outperformed any single protein. We also demonstrated that tumour-derived exosomes promoted tumour cell migration, but not proliferation and apoptosis. Our study indicates that CRP, VWF, and LRG are potential clinically relevant OSCC biomarkers. OSCC-related SEs may help promote migration of oral cells.
Exosomes in Oral Diseases: Mechanisms and Therapeutic Applications.
Miao Q, Li S, Lyu W, Zhang J, Han Y Drug Des Devel Ther. 2025; 19:457-469.
PMID: 39867866 PMC: 11766710. DOI: 10.2147/DDDT.S505355.
Emerging roles of exosomes in oral diseases progression.
Wang J, Jing J, Zhou C, Fan Y Int J Oral Sci. 2024; 16(1):4.
PMID: 38221571 PMC: 10788352. DOI: 10.1038/s41368-023-00274-9.
Wong S, Tey S, Mao X, Fung H, Xiao Z, Wong D Adv Sci (Weinh). 2023; 10(26):e2302677.
PMID: 37387563 PMC: 10502836. DOI: 10.1002/advs.202302677.
Gattuso G, Crimi S, Lavoro A, Rizzo R, Musumarra G, Gallo S Noncoding RNA. 2022; 8(4).
PMID: 36005828 PMC: 9414906. DOI: 10.3390/ncrna8040060.
Current Status, Opportunities, and Challenges of Exosomes in Oral Cancer Diagnosis and Treatment.
Liu H, Huang Y, Huang M, Huang Z, Wang Q, Qing L Int J Nanomedicine. 2022; 17:2679-2705.
PMID: 35733418 PMC: 9208818. DOI: 10.2147/IJN.S365594.